| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/15/2004 | US20040071725 Administered with target antigens to treat infections; anticarcinogenic and antitumor agents; genetic engineering |
| 04/15/2004 | US20040071724 Heat shock protein-based vaccines and immunotherapies |
| 04/15/2004 | US20040071723 Heat shock protein-based vaccines and immunotherapies |
| 04/15/2004 | US20040071722 Heat shock protein-based vaccines and immunotherapies |
| 04/15/2004 | US20040071721 A fusion protein of antigen and heat shock protein; DNA therapy promoting gene expression in mammal cells, treating infectious diseases and cancers, tumors; polynucleotide construct vectors |
| 04/15/2004 | US20040071720 A fusion protein of antigen and heat shock protein; DNA therapy promoting gene expression in mammal cells, treating infectious diseases and cancers, tumors; polynucleotide construct vectors |
| 04/15/2004 | US20040071719 Uses for polycationic compounds |
| 04/15/2004 | US20040071716 An adjuvant is used in vaccine formulation, comprising a polymeric emulsifier Arlacel" or ATLOX"; stable, low viscosity |
| 04/15/2004 | US20040071715 A capsule comprising a formaldehyde-treated antigens dispersed within a biocompatible polymer and an amino acid stabilizer as antiagglomerants; sustained release |
| 04/15/2004 | US20040071711 Imaging, diagnosis and treatment of disease |
| 04/15/2004 | US20040071692 Minimizes toxicity to normal tissue; high therapeutic index |
| 04/15/2004 | US20040071691 Including compatible solute; enhancing effectiveness of protein containing active material; reducing cytotoxic activity |
| 04/15/2004 | US20040071690 High avidity polyvalent and polyspecific reagents |
| 04/15/2004 | US20040071664 Delivery of an agent |
| 04/15/2004 | US20040071656 Modulation of heat-shock-protein-based immunotherapies |
| 04/15/2004 | US20040071654 Delivering labile agents; buffering effect; transfecting nucleic acids; nontoxic |
| 04/15/2004 | US20040070102 Novel process |
| 04/15/2004 | US20040069300 For the production of capsules and coatings for solid formulations in drug, cosmetic, food and dietetic fields, and for coating seeds. |
| 04/15/2004 | DE10296335T5 Pharmazeutische Formulierungen Pharmaceutical formulations |
| 04/15/2004 | DE10246125A1 Konzentrat eines Faktor VIII:C-haltigen von-Willebrand-Faktors und das dazu gehörige Verfahren Concentrate of factor VIII: C-containing von Willebrand factor and the associated method |
| 04/15/2004 | CA2836959A1 Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
| 04/15/2004 | CA2501981A1 Nitroxide radioprotector formulations and methods of use |
| 04/15/2004 | CA2500897A1 Long-acting gonadotropin-releasing hormone analogs and methods of use thereof |
| 04/15/2004 | CA2500833A1 Tumor targeting agents and uses thereof |
| 04/15/2004 | CA2500389A1 Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
| 04/14/2004 | EP1408066A1 Block copolymer reduced in impurity content; polymeric carrier; pharmaceutical preparations in polymeric form and process for the preparation of the same |
| 04/14/2004 | EP1408034A1 Use of Quinoline derivatives as antibacterial agents |
| 04/14/2004 | EP1407787A1 Method of promoting nucleic acid transfer |
| 04/14/2004 | EP1407786A1 Therapeutic inhibitor of vascular smooth muscle cells |
| 04/14/2004 | EP1407785A1 Medicinal compositions |
| 04/14/2004 | EP1407775A1 Medical preparation for parenteral injection |
| 04/14/2004 | EP1407765A1 Vesicles with chimeric receptors to induce a targeted T-cell response in vivo |
| 04/14/2004 | EP1407764A1 Implants for administering substances and methods of producing implants |
| 04/14/2004 | EP1407761A1 Stable hydroalcoholic compositions |
| 04/14/2004 | EP1407267A2 Gel compositions |
| 04/14/2004 | EP1407008A2 Influenza vaccine composition |
| 04/14/2004 | EP1406995A1 Azeotrope-like compositions of tetrafluoroethane pentafluoropropane, methylbutane and water |
| 04/14/2004 | EP1406951A1 Keratin-based products and methods for their production |
| 04/14/2004 | EP1406946A1 Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug |
| 04/14/2004 | EP1406929A2 Glycoprotein vi fusion proteins |
| 04/14/2004 | EP1406699A1 Antitumoral formulations of thioxanthenone |
| 04/14/2004 | EP1406680A1 Biofunctional fibers |
| 04/14/2004 | EP1406678A1 Drug delivery matrices to enhance wound healing |
| 04/14/2004 | EP1406662A1 Pharmaceutical formulation for the intramuscular administration of fulvestrant |
| 04/14/2004 | EP1406661A1 Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects |
| 04/14/2004 | EP1406658A1 Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan |
| 04/14/2004 | EP1406657A1 A novel engineered superantigen for human therapy |
| 04/14/2004 | EP1406647A1 Use of antimicrobial peptides as preservatives in ophthalmic preparations including solutions emulsions and suspensions |
| 04/14/2004 | EP1406633A1 Enhanced drug delivery in transdermal systems |
| 04/14/2004 | EP1406616A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 04/14/2004 | EP1406608A2 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 04/14/2004 | EP1406604A2 Topical application of muscarinic analgesic drugs such as neostigmine |
| 04/14/2004 | EP1406599A1 Cosmetic and dermatological preparations containing creatine for treating and actively preventing dry skin and other negative alterations of the physiological homeostasis of healthy skin |
| 04/14/2004 | EP1406598A1 Lymphatic drug delivery system |
| 04/14/2004 | EP1406597A1 Controlled drug delivery systems providing variable release rates |
| 04/14/2004 | EP1406596A1 Zero order controlled drug delivery system |
| 04/14/2004 | EP1406594A1 Controlled agglomeration |
| 04/14/2004 | EP1406593A2 Biodegradable polymer compositions, compositions and uses related thereto |
| 04/14/2004 | EP1406592A2 A salt/ion pair medicinal aerosol formulation |
| 04/14/2004 | EP1406591A1 Pharmaceutical composition for nasal delivery of estradiol and norethisterone |
| 04/14/2004 | EP1406573A2 Conditioned cell culture media and uses thereof |
| 04/14/2004 | EP1406572A2 Pediatric formulation of gatifloxacin |
| 04/14/2004 | EP1406571A2 Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints |
| 04/14/2004 | EP1406568A1 Sequential drug delivery systems |
| 04/14/2004 | EP1406513A1 Protein-containing foodstuff comprising a cross-linking enzyme and a hydrocolloid |
| 04/14/2004 | EP1406495A1 Method for reducing muscle fatigue through administration of adenosine triphosphate |
| 04/14/2004 | EP1406493A1 Administration of agents via the pept-2 transporter |
| 04/14/2004 | EP1351696A4 Composition for delivery of hematopoietic growth factor |
| 04/14/2004 | EP1210361B1 Stabilisation of freeze-dried cake |
| 04/14/2004 | EP1209971A4 Charge reversal of polyion complexes |
| 04/14/2004 | EP1183538B1 Cyclodextrin polymers for use as drug carriers |
| 04/14/2004 | EP1181038B1 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals |
| 04/14/2004 | EP1163012A4 Methods for inhibiting the formation of endoleaks associated with endovascular repair of abdominal aortic aneurysms |
| 04/14/2004 | EP1131071B1 Nicotine-containing pharmaceutical compositions giving a rapid transmucosal absorption |
| 04/14/2004 | EP1105399B1 Carboxylated phosphatidic acid esters |
| 04/14/2004 | EP1015490B1 No-modified hemoglobins and uses therefor |
| 04/14/2004 | EP0993337B1 Hydrophilic polymeric material and method of preparation |
| 04/14/2004 | EP0971972B1 Polymers with thiol terminal function |
| 04/14/2004 | EP0928206B1 A hydrocolloid wound gel |
| 04/14/2004 | EP0748213B1 Methods and compositions for pulmonary delivery of insulin |
| 04/14/2004 | EP0525199B2 Composition containing ultrafine particles of magnetic metal oxide |
| 04/14/2004 | CN1489597A N-oxy-group-contained lipids |
| 04/14/2004 | CN1489477A Conjugates of glycosylated/galactosylated peptide, bifunctional linker and nucleotidic monomers/polymers, and related compositions and method of use |
| 04/14/2004 | CN1489476A Method of preparing biological materials and preparation produced using same |
| 04/14/2004 | CN1489472A Improved mycoplasma hyopneumoniae bacterin vaccine |
| 04/14/2004 | CN1489468A Steroid hormone products and preparing method thereof |
| 04/14/2004 | CN1489466A Parenteral dosage containing epothilones |
| 04/14/2004 | CN1489457A Clear and stable propofol composition |
| 04/14/2004 | CN1489456A Pharmacentical formulation |
| 04/14/2004 | CN1489455A Delayed release pharmaceutical formulations |
| 04/14/2004 | CN1488404A Compounding use of sodium hyaluronate for eye preparation |
| 04/14/2004 | CN1488403A Calcium alginate/poly arginine-chitin glycan composite medicine release -controlled microcap sule and preparing method thereof |
| 04/14/2004 | CN1488350A Eye preparation for mulating prescription suitable for ciprofloxacin and use method thereof |
| 04/14/2004 | CN1488342A Compressed-shaping formulation for hypnosis |
| 04/14/2004 | CN1488331A Ultra porous hydrogel complex substance, preparing method and use in pharmaceutics thereof |
| 04/14/2004 | CN1145661C Biodegradable and thermosensitive polyphosphazenes and their prepn. method |
| 04/14/2004 | CN1145660C Hair conditioner and use |
| 04/14/2004 | CN1145641C Monomeric insulin analog formulations |
| 04/14/2004 | CN1145496C Novel formulation for peptide release |
| 04/14/2004 | CN1145491C Acidified nitrite as an antimicrobial agent |